未登录

Y

Yasmin M. Ahmed

nile valley university egypt

H指数:11

被引数:322

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing losartan potassium against rheumatoid arthritis via transdermally-delivered leciplexes: Accentuated efficacy through modulation of angiotensin II/AT1R/AT2R axis

通过经皮递送的leciplexes对氯沙坦钾进行再利用治疗类风湿性关节炎：通过调节血管紧张素II/AT1R/AT2R轴增强疗效

international journal of pharmaceutics

IF0

2025-07-010

OAAI

Repurposing celecoxib for colorectal cancer targeting via pH-triggered ultra-elastic nanovesicles: Pronounced efficacy through up-regulation of Wnt/β-catenin pathway in DMH-induced tumorigenesis

international journal of pharmaceutics

IF6.4

2024-06-018

OAAI

yRestoring glomerular filtration rate by sulforaphane modulates ERK1/2/JNK/p38MAPK, IRF3/iNOS, Nrf2/HO-1 signaling pathways against folic acid-induced acute renal injury in rats

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-10-019

PRE

Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2023-03-318

PRE

Brain Targeting of Citicoline Sodium via Hyaluronic Acid-Decorated Novel Nano-Transbilosomes for Mitigation of Alzheimer's Disease in a Rat Model: Formulation, Optimization, in vitro and in vivo Assessment

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2022-12-017

OAAI

The protective effect of thymoquinone or/and thymol against monosodium glutamate-induced attention-deficit/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2/HO-1, TLR4/NF-ΚB/NLRP3/caspase-1 and Wnt/β-Catenin signaling pathways in rat model

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-11-0121

OAAI

Partial Synthetic PPARΥ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression

PHARMACEUTICALS

IF4.8

2022-09-223

OAAI

Novel Bile Salt Stabilized Vesicles-Mediated Effective Topical Delivery of Diclofenac Sodium: A New Therapeutic Approach for Pain and Inflammation

PHARMACEUTICALS

IF4.8

2022-09-0521

OAAI

Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation

IF5.5

2022-07-2313

OAAI

Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway

PHARMACEUTICALS

IF4.8

2022-03-109

OAAI

Development and Greenness Assessment of HPLC Method for Studying the Pharmacokinetics of Co-Administered Metformin and Papaya Extract

IF4.6

2022-01-073

OAAI

Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro

PHARMACOLOGICAL REPORTS

IF3.8

2019-12-0116

PREAI